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Abstract
With the recent emergence of a novel pandemic strain, there is presently intense interest in understanding the molecular
signatures of virulence of influenza viruses. PB1-F2 proteins from epidemiologically important influenza A virus strains were
studied to determine their function and contribution to virulence. Using 27-mer peptides derived from the C-terminal
sequence of PB1-F2 and chimeric viruses engineered on a common background, we demonstrated that induction of cell
death through PB1-F2 is dependent upon BAK/BAX mediated cytochrome c release from mitochondria. This function was
specific for the PB1-F2 protein of A/Puerto Rico/8/34 and was not seen using PB1-F2 peptides derived from past pandemic
strains. However, PB1-F2 proteins from the three pandemic strains of the 20
th century and a highly pathogenic strain of the
H5N1 subtype were shown to enhance the lung inflammatory response resulting in increased pathology. Recently
circulating seasonal influenza A strains were not capable of this pro-inflammatory function, having lost the PB1-F2 protein’s
immunostimulatory activity through truncation or mutation during adaptation in humans. These data suggest that the PB1-
F2 protein contributes to the virulence of pandemic strains when the PB1 gene segment is recently derived from the avian
reservoir.
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Introduction
For the first time in more than 40 years, a novel influenza virus
has emerged from an animal reservoir and caused a human
pandemic [1]. In contrast to the three pandemics of the 20
th
century, most disease from the novel H1N1 pandemic influenza
virus has been mild [2]. The reasons for this disparity in
pathogenesis are unclear because the molecular signatures of
virulence of pandemic viruses are not known. A comparison of the
genesis of the three 20
th century pandemics reveals that only 2
unique gene segments were reassorted from the avian reservoir in
every case - hemagglutinin (HA) and PB1 [3]. It is accepted that
antigenic novelty is required for a virus to achieve pandemic
status, explaining why the HA gene has been new in past
pandemics. However, the significance of inclusion of a novel PB1
gene segment in each of the 20
th century pandemics is not yet
understood. The discovery of the PB1-F2 protein, which is
translated from the +1 reading frame of the PB1 gene segment,
may be a clue [4]. If this gene product contributes to virulence, it
may serve as a marker of the pathogenicity of pandemic strains.
Intriguingly, the 2009 pandemic H1N1 contains a PB1 gene
segment that is thought to have been derived from human viruses
and to have been evolving in swine for approximately 15 years
[5,6]. Its PB1-F2 open reading frame is truncated after a predicted
11 amino acids and is therefore likely non-functional if it is
expressed.
PB1-F2 is a short (87–90 a.a.) influenza A virus protein
discovered in 2001 [4]. After expression, it is rapidly degraded and
it is not required for viral replication in ovo or in cultured cells [4].
The PB1-F2 protein is recognized by the human immune system,
resulting in both humoral and T-cell responses during infections
with seasonal H3N2 or highly pathogenic H5N1 viruses [4,7,8].
Expression of PB1-F2 has been shown to enhance viral
pathogenicity in mouse models of influenza A virus infection
[9,10].
The precise contribution of PB1-F2 to virulence and its function
in the life cycle of influenza A viruses in mammalian hosts are
unclear. The C-terminal portion of the PB1-F2 open reading
frame contains a mitochondrial targeting sequence [4]. Expression
of full length PB1-F2 has been associated with mitochondrial
targeting and apoptosis [4,11] and it has been suggested that
mitochondrial disruption with subsequent cell death could
contribute to virulence [11,12]. A suggested second function of
the PB1-F2 protein, causing immunopathology by enhancing the
inflammatory response, has been demonstrated in animal models
of influenza disease [10,13]. This mechanism for increased
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1918 pandemic strain was expressed, arguing for clinical relevance
[10,13]. Finally, the PB1-F2 protein has been shown to bind PB1
in vitro, and it has been proposed that this might enhance
transcription by increasing nuclear retention time [14]. Down-
stream effects on replication were predicted to enhance virulence.
We have recently demonstrated, however, that this third property
of PB1-F2 is cell-type and virus strain specific and does not result
in changes in viral lung load or pathogenicity in vivo [15].
Building on the results from our recent report examining the
effects of PB1-F2 on viral replication [15], we analyze here the
PB1-F2 protein’s contribution to pathogenesis in a mouse model in
the context of the other two proposed mechanisms, cell death and
enhanced inflammation. To demonstrate the relevance of the
results to human disease, PB1-F2 proteins from a variety of
epidemiologically important influenza A virus strains including all
pandemic strains from the 20
th century, a highly pathogenic avian
influenza virus of the H5N1 subtype, and representative seasonal
strains were utilized. We show here that the ability to cause cell
death through PB1-F2 mediated mitochondrial interactions is
specific to the laboratory strain A/Puerto Rico/8/34 (H1N1; PR8)
among the viruses studied, arguing this function is not a likely
contributor to pathogenicity in humans with most epidemiolog-
ically relevant strains. However, the capacity to enhance the
inflammatory response is a general feature of PB1-F2 proteins
encoded by PB1 genes that are direct introductions from the avian
gene pool. These PB1 genes contributed to the formation of all
pandemic strains of the 20
th century and from the currently
circulating highly virulent H5N1 strain that constitutes an
imminent pandemic threat. The significance of these findings for
future pandemic preparation and for understanding of the current
H1N1 pandemic are discussed.
Results
PB1-F2 induction of cell death is virus strain specific
Influenza viruses have the capability to subvert host immunity
by several mechanisms. It has been suggested that down-regulation
of the host immune response through apoptosis of responding
immune effector cells by PB1-F2 might contribute to virulence
[12]. However, effects of PB1-F2 on cell death have been
contextual; the protein’s apoptotic effects have been cell type
specific, have differed dependent on infection with whole virus vs.
expression of PB1-F2 alone, and to this point have only been
studied using the laboratory strain PR8. We reasoned that if this
mechanism formed an integral component in the influenza A virus
strategy for down-regulation of the host immune response to
infection, then induction of cell death would be mediated by PB1-
F2 proteins from several epidemiologically important influenza A
virus strains.
Peptides derived from PB1-F2 C-terminal sequences of PR8, the
three 20
th century pandemic strains (1918, 1957, 1968), a recent
highly pathogenic avian influenza virus of the H5N1 subtype, and
a recent seasonal H3N2 strain were synthesized for study [10,15]
(Figure 1). Recent seasonal H1N1 strains express a form of PB1-F2
truncated after 57 amino acids, lacking the mitochondrial
targeting sequence located in the C-terminal region, and thus
could not be evaluated in this manner [15,16]. The predicted
secondary structures of these peptides were determined by circular
dichroism and match the reported structure of this region as
described for full-length protein and 44-mer peptides [17,18] (data
Author Summary
There is presently great interest in understanding how
influenza viruses cause disease. In this paper, we explore
the role of the influenza virus PB1-F2 protein in disease.
We show that the ability of the protein to cause cell death
is mediated through a mitochondrial death pathway
controlled by proteins called BAX or BAK. However, this
function of the protein only seems to be relevant to a
restricted set of viruses and not past pandemic strains.
Instead, the ability to generate inflammation in the lung
proves to be a common trait of all past pandemic strains as
well as the H5N1 highly pathogenic avian influenza strains
which remain a significant pandemic threat. It appears
likely that this pro-inflammatory phenotype is a charac-
teristic of viruses emerging from the avian reservoir and is
therefore important for new strains that cross the species
barrier and establish themselves in humans. During
circulation and adaptation in the mammalian lung, this
function is typically lost. Of note, the novel 2009 H1N1
pandemic strain does not express a full-length PB1-F2.
Were it to acquire a fully functional, inflammatory PB1-F2
through reassortment, this could herald greatly enhanced
disease potential.
Figure 1. PB1-F2 sequences of viruses used in this study. A comparison of the predicted amino acid sequences of the C-terminal regions of
PB1-F2 proteins of several epidemiologically important strains is presented. Colored lines at the bottom of the Figure represent the amino acid
composition of the predicted helical region (blue), the 27-mer peptides used in this study (green), and the predicted mitochondrial targeting
sequence (red). Blue shading highlights differences in predicted amino acid sequence between the seasonal (1995) and pandemic (1968) H3N2
strains. Yellow shading indicates amino acids predicted to be involved in the cell death phenotype of PR8 (see discussion). Green shading highlights
the N66S mutation, a predicted virulence determinant for the 1918 pandemic strain [13].
doi:10.1371/journal.ppat.1001014.g001
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cells in vitro, and are observed to have similar intracellular
distributions and kinetics of degradation as does full length protein
expressed from the virus (Figure S1; Text S1).
First, we exposed the human lung epithelial cell line A549 and
the BalbcJ mouse derived macrophage cell line RAW264.7 to the
panel of peptides for 1 hour at a final concentration of 50mM.
Evaluation of necrosis via flow cytometric analysis of Annex-
inV
+PI
+ events revealed that only the peptide derived from the
laboratory strain PR8 induced a significant amount of cell death in
the human epithelial cell line A549 (Figure 2A). Both PR8 and the
peptide derived from the 1918 pandemic strain caused cell death
in RAW264.7 cells (Figure 2B), but the 1918 peptide had no effect
in A549. Exposure of RAW264.7 or A549 cells to peptides derived
from virus strains other than those derived from PR8 or the 1918
strain did not affect viability, similar to exposure to an N-terminal
peptide control or unexposed controls. There were negligible
AnnexinV
+ only events in either cell line exposed to peptides,
which suggests that the cells were dying as a result of necrosis in
this assay, rather than apoptosis.
To evaluate whether PB1-F2 protein expression in the context
of viral infection had similar effects on induction of cell death, we
next infected A549 or RAW264.7 cells with a panel of
recombinant viruses at an MOI of 1 for 2–12 hours. This panel
included previously described viruses unable to express PB1-F2
(DPB1-F2/PR8), or expressing the PB1-F2 of the 1918 pandemic
strain (1918 PB1-F2/PR8) or the truncated 1956 H1N1 strain
(Beij PB1-F2/PR8) [10,15]. In addition, two previously described
viruses [15] in a 7 gene segment PR8 background (7:1 reassortants)
and encoding PB1 gene segments from a 2004 highly pathogenic
Figure 2. PB1-F2 causes cell death. Induction of cell death was determined in human epithelial A549 and mouse macrophage RAW264.7 cell lines
by detection of Annexin
+PI
+ events after A & B) exposure to a panel of 27-mer peptides derived from the C-terminal region of the PB1-F2 protein (see
Figure 1 for definition), an N-terminal 27-mer peptide derived from PR8 (final concentration 50 mM for each peptide), or no peptide for 1 hour; and
infection with a panel of recombinant virus (see methods for definitions of viruses; the H3N2 PB1 is from A/Wuhan/359/95) at a multiplicity of
infection of 1.0 at C) 12 hours and D) 8 hours post-infection. An asterisk (*) indicates a significant difference compared to A) all other peptides and
controls, B) all peptides and controls except PR8 and 1918, C &D) all viruses with a PB1 gene segment derived from an H1N1 virus and the no virus
control by ANOVA (p,0.05).
doi:10.1371/journal.ppat.1001014.g002
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1995 human H3N2 strain (H3N2 PB1/PR8) were utilized along
with their isogenic deletion mutants for PB1-F2 (H5N1 DPB1-F2/
PR8 and H3N2 DPB1-F2/PR8). Using confocal microscopy we
demonstrated that PB1-F2 proteins from the viruses which were
utilized in this study and which have an intact PB1-F2 ORF are
expressed and distribute throughout the cell (Figure S2; Text S2)
and [15].
As has been demonstrated previously [4,11,12], PR8 virus
induces significant cell death compared to uninfected controls
(Figure 2C, D). PB1-F2 has been shown to be maximally produced
at 6–8 hours post-infection in these cells types [15] and only
minimal cell death was appreciated in the first 6 hours post
infection (data not shown). When RAW264.7 cells were infected
with PR8 virus, necrotic death peaked 8 hours after infection,
while in A549 cells it peaked 12 hours post infection. The inability
of the DPB1-F2/PR8 to express PB1-F2 and the truncation of the
C-terminal portion of Beij PB1-F2/PR8 abrogated the ability of
both viruses to cause cell death in both cell types (Figure 2C, D).
Interestingly, however, expression of the 1918 PB1-F2, which has
been associated with enhanced virulence [10,13], did not cause
significant increases in cell death over controls. In addition,
deletion of PB1-F2 in either an H3N2 or H5N1 PB1 gene segment
background did not alter the cell death phenotype of chimeric
viruses expressing those PB1s. We conclude from these data that
the ability to cause cell death through PB1-F2 is a property of
specific strains and is unlikely to have contributed to the
pathogenicity of the 20
th century influenza virus pandemics or
recent seasonal epidemics.
PR8 PB1-F2 promotes BAK/BAX-dependent
mitochondrial outer membrane permeabilization
It has been suggested that PB1-F2 is able to induce cell death by
disrupting mitochondrial organization through interaction with
inner mitochondrial membrane adenine nucleotide translocator 3
(ANT3) and the outer mitochondrial membrane voltage channel 1
(VDAC1) to produce a mitochondrial permeability transition [12].
Alternatively, the PR8 PB1-F2 has been shown to permeabilize
planar membranes, and thus may be able to directly permeabilize
mitochondria [19]. We therefore probed the mechanism under-
lying the induction of cell death mediated by the PR8 PB1-F2. We
hypothesized that the PB1-F2 C-terminal domain may promote
mitochondrial outer membrane permeabilization (MOMP) via the
activation of the pro-apoptotic Bcl-2 family effector proteins BAX
and BAK.
To test this hypothesis, we exposed isolated mitochondria
obtained from the livers of BALBcJ mice to various concentrations
of PR8 derived PB1-F2 peptide. Analysis of cytochrome c release
revealed that peptide derived from the laboratory strain PR8 could
promote MOMP. As PR8 is a mouse adapted laboratory strain
and initial experiments utilized only murine derived intact
mitochondria, we repeated peptide exposure experiments using
mitochondria obtained from liver tissue of chicken embryos,
outbred ferrets, and mallards. Results indicate that PR8 PB1-F2
derived peptide is a potent inducer of cytochrome c release and is
not species specific (Figure 3A). As little as 10mM PR8 PB1-F2
peptide was sufficient for inducing cytochrome c release from each
species analyzed. As different PB1-F2 proteins may display species
specificity in mitochondrial targeting by the PB1-F2 protein, we
next examined MOMP and release of cytochrome c using the
panel of different C-terminal PB1-F2 peptides and an N-terminal
peptide from PR8 as a negative control. Again, only the PR8 PB1-
F2 was able to promote MOMP (Figure 3B), irrespective of the
species from which the mitochondria were obtained. In contrast,
mitochondria obtained from the livers of bak-/-bax-/- mice did not
release cytochrome c when incubated with PB1-F2 C-terminal
peptide (Figure 3B). These data suggest that apoptosis induced by
the PR8 PB1-F2 protein is dependent upon BAK/BAX activation
and MOMP.
To determine BAK/BAX dependency for PR8 PB1-F2
induction of apoptosis at the cellular level, we treated wild-type
murine embryonic fibroblasts (MEFs) and bak-/-bax-/- MEFs with
the panel of PB1-F2 peptides and analyzed for apoptosis. The PR8
PB1-F2 derived peptide induced apoptosis in wild-type MEFs, but
peptides derived from other viruses did not show similar activity
(Figure 3C). However, apoptosis in bak-/-bax-/- MEFs was greatly
reduced such that PR8 PB1-F2 induction of cell death was
equivalent to cells exposed to the other peptides (Figure 3D).
Taken together, the cytochrome c release and apoptosis data
implicate PR8 PB1-F2 in BAK/BAX activation and the
mitochondrial pathway of apoptosis, but suggest that this effect
is specific to certain influenza virus strains.
PB1-F2 causes increased cellularity in bronchoalveolar
lavage fluid
PB1-F2 proteins from both laboratory viruses and clinically
relevant strains have been shown to contribute to primary viral
virulence [9,10,13] and to the pathogenesis of secondary bacterial
infections [10] in mice. This appears not to be related to the
proposed ability of PB1-F2 to enhance replication or cause cell
death, as both of these functions are limited to specific virus strains
([15] and this report). We therefore investigated the contribution
of several clinically relevant PB1-F2 proteins to immunopathology.
Mice were exposed to a panel of PB1-F2 derived peptides and
were euthanized 24 hours later for collection of bronchoalveolar
lavage fluid (BALF). C-terminal PB1-F2 peptides derived from
PR8, the pandemic strains from 1918 (H1N1), 1957 (H2N2) and
1968 (H3N2), and the 2004 H5N1 virus all caused significant
influx of white blood cells into the BALF compared to controls.
Several cell types were increased including T-cells (data not
shown), dendritic cells (data not shown), macrophages (Figure 4A)
and neutrophils (Figure 4B). Interestingly, the peptide derived
from a more recent H3N2 strain, A/Wuhan/359/1995, did not
cause an appreciable increase in inflammatory cells over controls.
When peptide exposed mice were followed for morbidity for 7
days, striking differences were seen comparing the five peptides
that caused inflammation with the 1995 H3N2 peptide and the
controls. The ‘‘pro-inflammatory’’ peptides caused huddling,
hunching, labored breathing, ruffled fur and weight loss which
peaked in the first 24–48 hours after exposure, while the ‘‘non-
inflammatory’’ exposures caused no clinical signs (data not shown)
or weight loss (Figure 4C). Thus, the ability to cause lung
inflammation appears to be a property of PB1-F2 proteins recently
emerged from the avian gene pool. H1N1 strains circulating in
humans since about 1950 have a truncated PB1-F2 that lacks the
C-terminal residues responsible for this effect and in contrast to
their pandemic forbear from 1968, recently circulating H3N2
strains lack a PB1-F2 capable of causing inflammation.
To assess the contribution of PB1-F2 to inflammation in the
context of a full virus, where expression of other proteins is likely to
contribute to the inflammatory response, we utilized the previously
described set of viruses on the PR8 backbone in a mouse infection
model. In data previously reported with these viruses, alteration or
abrogation of PB1-F2 did not result in significant differences in
weight loss, in the dose needed to cause death in mice, or in viral
lung titers 1, 3, 5 and 7 days after infection for any comparisons
except those previously reported for the 1918 PB1-F2 [10,15].
However, the differential effects of PB1-F2 expression could
Influenza Virus PB1-F2 and Inflammation
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Disruption of PB1-F2 expression in PR8 or replacement of the
PR8 PB1-F2 with the C-terminally truncated Beij PB1-F2 both
significantly reduced the number of white blood cells found in
BALF 3 days post viral infection (Figure 5A) compared to PR8.
This significant difference was maintained when specifically
assessing the influx of either macrophages or neutrophils
(Figure 5B, C). Expression of the 1918 PB1-F2 led to effects
similar to those of the PR8 virus. Use of the virus containing the
H5N1 PB1 gene segment in a PR8 background revealed that
disruption of PB1-F2 expression also significantly depressed the
inflammatory response compared to the virus maintaining the
ability to express full length PB1-F2 (Figure 5A, B, C). However, in
agreement with the peptide data, no differences were seen that
could be attributed to the 1995 H3N2 derived PB1-F2.
PB1-F2 causes inflammatory changes in the lung
Having determined that PB1-F2 drives an influx of inflamma-
tory cells into the lungs that is detectable in BAL fluid, we next
assessed the impact of this enhanced inflammatory response on
histopathologic changes in lung tissue. Groups of mice were
exposed to the panel of peptides and euthanized 24 or 72 hours
later for examination of the lungs by an experienced veterinary
pathologist (K.L.B.) who was blinded to the purpose of the study
and the composition of the groups. At the 24 hour timepoint, only
minimal perivascular changes were observed and no differences
were apparent between groups (data not shown). 72 hours after
exposure, however, significant pathology was observed in some
groups of mice compared to others, mirroring the dichotomy in
morbidity pictured in Figure 4C. Only minimal rare, perivascular
infiltration of lymphocytes around small vessels was observed in
mice exposed to the N-terminal control peptide or the peptide
derived from the H3N2 seasonal strain A/Wuhan/359/1995
(Figure 6E, F). However, in mice exposed to peptides derived from
the pandemic strains from 1918 and 1957, as well as the peptide
from a 2004 H5N1 strain, hypertrophy of type II pneumocytes
and thickening of alveolar septae were observed. Significant
infiltration of neutrophils and macrophages was noted in both
interstitial perivascular regions as well as within alveolar spaces
(Figure 6B–D). Macrophages grossly outnumbered neutrophils,
mirroring the findings in BAL fluid following peptide exposure
(Figure 4A, B).
Figure 3. PB1-F2 mediated cell death is virus strain specific. A & B) Analysis of MOMP via detection of cytochrome c release by western blot
after exposure to a panel of peptides (see Figure 1 for definitions) of heavy membrane fractions (mitochondria) derived from chicken, duck, ferret and
mouse livers (B includes mitochondria from bax-/-bak-/- mice). A) Mitochondria exposed to 1, 10, 100 and 1000 mM PR8 peptide for 1 hour show
release of cytochrome c into the supernatant (s). Pellet (p) contains intact mitochondria containing unreleased cytochrome c. B) Mitochondria were
exposed to the peptide panel and supernatants were analyzed for cytochrome c release. C8-BID was used as a positive control for mammalian
mitochondria. CHAPS solubilizes mitochondrial membranes, enabling release of total cytochrome c. C&D) Induction of cell death in C) wild-type and
D) bax-/-bak-/- murine embryonic fibroblasts (MEFs) after a 1 hour exposure to the panel of peptides (50 mM final concentration). An asterisk (*)
indicates a significant difference compared to all other peptides and controls by ANOVA (p,0.05).
doi:10.1371/journal.ppat.1001014.g003
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inflammatory changes were seen, but there was an additional
finding of direct alveolar wall damage with fibrin deposition and
copious necrotic debris filling the alveoli, suggestive of cell death
(Figure 6A). From these data and data presented in Figure 4, we
conclude that the major effect of exposure of mammalian lungs to
PB1-F2 proteins is generation of a macrophage and neutrophil
dominated inflammatory response which causes significant
immunopathology. Following adaptation of an H3N2 to humans,
this function has been lost. The additional capability of the PR8
PB1-F2 protein to cause cell death enhances the pathology seen in
the animals resulting in worse clinical outcomes. In titration of this
panel of peptides in mice, only the PR8 peptide caused fatal illness
(data not shown), suggesting that both functions of PB1-F2 can
contribute to fatal viral pneumonia.
To assess this inflammatory phenotype in the context of a full
virus, mice were infected with WT PR8, 1918 PB1-F2/PR8,
DPB1-F2/PR8, or Beij PB1-F2/PR8 and were euthanized
72 hours later for histopathologic examination as described above.
In all lungs examined, pathologic changes typical of PR8 viral
infection were observed, including perivascular infiltration of
lymphocytes into interstitial regions, areas of focal necrosis of
terminal airways and prominent cellular debris associated with
acute hemorrhage into alveoli (Figure 7A). In the lungs of mice
infected with PR8 or 1918 PB1-F2/PR8, however, significantly
more perivascular cuffing was noted, consisting of an admixture of
both viable and degenerate neutrophils and macrophages. The
number of inflammatory cells seen in both the interstitium and
alveoli was noticeably greater in these mice than in mice infected
with DPB1-F2/PR8 or Beij PB1-F2/PR8. This finding supports
the BAL data presented in Figure 5 and the histopathologic
changes caused by the PB1-F2 peptide alone in Figure 6. Staining
for myeloperoxidase (MPO) highlighted the influx of granulocytes
and resulting inflammation in the lungs of mice infected with PR8
or 1918 PB1-F2/PR8 and was significantly more intense in these
lungs compared to the DPB1-F2/PR8 or Beij PB1-F2/PR8
infected lungs (Figure 7B). We conclude that expression of full
length PB1-F2 enhances lung inflammation during influenza virus
pneumonia and increases the pathologic damage that occurs.
During infections with viruses such as PR8 that are capable of
causing PB1-F2 mediated cell death and inflammation by an
unrelated mechanism, the lung injury is enhanced.
Figure 4. PB1-F2 peptides enhance inflammation in the lung. Groups of mice were exposed to a panel of peptides (100 mM final
concentration, see Figure 1 for definitions) and euthanized 24 hours later. BAL fluid from the animals was assayed by flow-cytometry [10] for the
mean number of A) macrophages and B) neutrophils compared to unexposed mice or mice exposed to an N-terminal control peptide. An asterisk (*)
indicates a significant difference compared to the 1995 H3N2 peptide and controls by ANOVA (p,0.05). A double asterisk (**) indicates a significant
difference compared to the controls. Error bars indicate the standard deviation from the mean. C) In a separate set of experiments, mice exposed to
peptide were monitored for overt signs of illness and percentage change from initial weight. For clarity, peptides are grouped by their inflammatory
potential as determined in A & B.
doi:10.1371/journal.ppat.1001014.g004
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The data presented here demonstrate the capacity of the
influenza A virus PB1-F2 protein to enhance the lung inflamma-
tory response in a mouse model. This study is the first to explore
the function of PB1-F2 utilizing PB1-F2 proteins from several
different, epidemiologically important influenza A virus strains.
These strains included those containing novel PB1 gene segments
contributing to the formation of all pandemic strains of the 20th
century and from the currently circulating, highly virulent H5N1
strains that constitute an imminent pandemic threat. The
inflammatory response engendered by PB1-F2 was characterized
by increased cellular infiltrates into the interstitial and alveolar
spaces of the lungs, which largely consisted of macrophages and
neutrophils. Among the viruses assessed, induction of inflamma-
tion by PB1-F2 was a property restricted to proteins encoded by
PB1 gene segments that were direct introductions from the avian
gene pool. Seasonal strains which had adapted to humans lacked a
PB1-F2 capable of causing inflammation. One important caveat is
that these experiments were done on a PR8 background, so
further study of these PB1-F2 proteins in their native background
is indicated. Our analysis of MOMP utilizing mitochondria from
several animal species and study of cell death relating to PB1-F2
expression implicate the PR8 PB1-F2 in BAK/BAX activation
and the mitochondrial pathway of apoptosis. However, induction
of cell death via mitochondrial association was specific only to the
PB1-F2 protein of the laboratory strain of PR8 in these studies and
is not a general property of all PB1-F2 proteins.
All influenza viruses infecting humans are zoonotic reassortants
comprised of gene segments that derive ultimately from an avian
reservoir of precursor strains. It has been appreciated for some
time that one of the requirements for emergence of a pandemic
strain is antigenic novelty of the HA, which facilitates high clinical
attack rates [20]. However, the molecular signatures contributing
to another criterion for pandemic strains, the ability to cause
serious disease, are not clear at present. The inclusion of a novel
PB1 gene segment in each of the virulent 20
th century pandemics
may be an intriguing clue. Evidence presented here implicates full
length PB1-F2 protein expression, encoded by a +1 open reading
frame of the PB1 gene segment, as a marker of pathogenicity of
20
th century pandemic strains. The pro-inflammatory capability of
the H5N1 PB1-F2 demonstrated by this study provides further
reason for concern that this subtype represents a serious pandemic
threat, although significant sequence diversity exists among avian
strains and the specific molecular signatures for the inflammatory
phenotype are not yet known. Full length PB1-F2 proteins are
expressed by nearly all avian influenza virus strains [16], but
analysis of lineages after introduction of these strains into humans
or pigs show evidence of permanent truncation during adaptation
in mammalian hosts. This pattern implies that there is some
functional utility for the protein in birds that is not evolutionarily
advantageous for the virus in mammals. We speculate that the
inflammatory property of PB1-F2 described here facilitates
transmission from the natural host niche of influenza viruses in
waterfowl, the gut, by increasing luminal secretions. If induction of
inflammation in the lung is detrimental or neutral to the virus
during its life-cycle in mammalian hosts, this function might be lost
over time during adaptation despite a lack of evidence for strong
positive selection pressure on the protein [21]. This is an obvious
area for further study in relevant species.
In humans, the H1N1 PB1-F2 lineage introduced in 1918
became truncated around 1948–1950 (Figure 1), losing the C-
terminal region that contains the mitochondrial targeting sequence
[4,22] and promotes inflammation (this report). The currently
Figure 5. PB1-F2 enhances viral-mediated lung inflammation.
Groups of mice were infected with a panel of viruses (see methods for
definitions) and euthanized 72 hours post-infection. BAL fluid from the
animals was assayed by flow-cytometry [10] for the mean number of A)
white blood cells, B) macrophages, and C) neutrophils compared to
uninfected mice or mice infected with a virus lacking the ability to
express PB1-F2. An asterisk (*) indicates a significant difference
compared to animals infected with the DPB1-F2/PR8 or Beij PB1-F2/
PR8 viruses, and uninfected control animals by ANOVA (p,0.05). A
double asterisk (**) indicates a significant difference compared to
animals infected with the Beij PB1-F2/PR8 virus and uninfected control
animals. A triple asterisk (***) indicates a significant difference
compared to animals infected with the H5N1 DPB1-F2/PR8 virus and
uninfected control animals. Error bars indicate the standard deviation
from the mean.
doi:10.1371/journal.ppat.1001014.g005
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have undergone evolutionary changes during adaptation. In this
study we demonstrate that PB1-F2 derived from the 1968
pandemic strain can cause lung inflammation, but that from a
recently circulating seasonal H3N2 cannot. Analysis of the PB1-F2
C-terminal regions of these strains shows that only 5 amino acid
differences are found within the region selected for generating the
peptides used to study inflammation (Figure 1). Two of these
changes, K73R and R75H, are within the MTS at positions shown
by alanine substitution to be important for mitochondrial targeting
[22]. However, both changes are conservative in terms of charge,
and the A/Wuhan/359/1995 PB1-F2 shows mitochondrial
localization by confocal microscopy (Figure S2). This suggests
alteration of mitochondrial targeting by mutation is not respon-
sible for the change in phenotype. A clear priority is to understand
which of these mutations, or what combination of them, is
responsible for the diminished capacity of the 1995 H3N2 strain to
generate inflammation. This may allow prediction of which avian
or swine PB1 gene segment precursors represent a pandemic
threat were they to reassort onto a virus crossing the species
barrier. Only one other amino acid change, the N66S change in
the 1918 PB1-F2 (Figure 1), has been associated with a gain in
virulence [13]. However, an S at position 66 is not necessary for
enhancement of inflammatory responses since the other pro-
inflammatory PB1-F2 proteins studied here do not possess this
residue at that position.
One of the hypotheses advanced in our earlier work [10] to
explain the immunopathogenic phenotype of the 1918 pandemic
strain PB1-F2 was that the previously described cell death
phenotype [4,11] was responsible for the inflammatory response
by killing lung cells resulting in activation of local host defenses.
However, the dissociation between cell death and immunopathol-
ogy demonstrated in this report, in particular the inability of the
1918 PB1-F2 to activate mitochondrial cell death pathways,
suggests that the immunostimulatory activity of PB1-F2 is a direct
effect. PB1-F2 is expressed early in the course of infection [10] and
has a short half-life [4]. This suggests that the trigger for these
inflammatory responses is likely to take place early during
infection, perhaps by direct recognition of PB1-F2 by pattern
recognition receptors. Finding the potential binding partner of
PB1-F2 in this pathway is of obvious interest and is a focus of
ongoing studies. Although antibody is generated in humans which
can recognize PB1-F2 [7], it is not known whether this can
modulate the functional outcomes of PB1-F2 expression and
decrease disease. One additional caveat for these studies is that
deletion of the PB1-F2 start codon has been shown to affect
expression levels of a truncated version of PB1, the N40 protein
[23]. Although N40 over-expression was not shown to alter viral
replication in that study, it could have unknown effects in vivo that
could complicate interpretation of our experiments with PB1-F2
knock-out viruses.
Since its discovery the consensus has been that the PB1-F2
proteins from selected viruses are pro-apoptotic, targeting the
mitochondria and inducing pore formation through association
with VDAC1 and ANT3 [4,11,12,19,24]. ANT3 and VDAC1
molecules are major components of the permeability transition
Figure 6. PB1-F2 derived peptides cause inflammation and lung pathology. Groups of mice were exposed to a panel of peptides (100 mM
final concentration, see Figure 1 for definitions) and euthanized 72 hours later. Lungs were removed, sufflated, sectioned, and stained with
hematoxylin and eosin for histopathologic evaluation. Representative 406sections are shown from mice exposed to peptides derived from the PB1-
F2 protein of A) PR8, B) H1N1 1918, C) H2N2 1957, D) H5N1 2004, E) H3N2 1995, or F) no peptide control.
doi:10.1371/journal.ppat.1001014.g006
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release from the mitochondria, leading to the activation of the
caspase pathway and subsequent cell death. This ionic channel
however, becomes activated and induces membrane permeability,
following marked oxidative stress and altered mitochondrial
calcium levels [25]. Most of the available data surrounding the
apoptotic pathway suggest that BAK/BAX mediation of cyto-
chrome c release (irrespective of whether components of the
permeability transition pore complex are involved) mark apoptotic
cell death, whereas cytochrome c release exclusively mediated by
VDAC and ANT implies non-apoptotic, mainly necrotic cell
death [26]. We show conclusively that, among the viruses tested,
only the PB1-F2 C-terminal domain of the PR8 laboratory strain
efficiently engages the BAK/BAX pathway. The dependency for
presence of BAK/BAX expression on the PR8 induced pore
formation in mitochondria defines the role for PR8 PB1-F2 as a
BH3 only protein that activates conformational change in the
BAX complex within the mitochondria. Whether this complex
leads to association with the VDAC/ANT ion channel formation,
or activated BAX complex solely causes pore formation and
subsequent cytochrome c release, is currently not understood.
Analysis of the 5944 predicted amino acid sequences of PB1-F2
proteins available in the Influenza Research Database [27] in the
context of these data suggests that the ILV motif from amino acids
68–70 of the PR8 PB1-F2 ORF is likely to be involved in the cell
death phenotype (Figure 1). This is the only area of the C-terminal
portion of the PR8 sequence that differs between PR8 and other
strains studied herein. The 68I and 69L are present in only 17 of
these 5944 sequences, all from human viruses. The 70V is
invariably present when the 68I and 69L are present. Fourteen of
these viruses circulated between 1933 and 1947 and were of the
H1N1 subtype, and only 2 viruses with published PB1-F2
sequences from this era do not share this motif. The other 3
viruses with this motif are A/Victoria/68 (H3N2), A/TW/3355/
97 (H1N1), and A/Russia:St.Petersburg/8/06 (H1N1). The 1918
pandemic strain has the sequence TPV from amino acids 68–70;
this motif is shared with only 8 other sequences available in the
database. Having this unusual motif at this position and sharing
the 70V substitution with PR8 might account for the limited
ability of the 1918 PB1-F2 to cause necrosis in vitro (Figure 2),
although further study is needed to confirm this hypothesis. The
other viruses studied in this report have more common motifs at
these three positions, and both F and S are commonly found at
position 71 making it an unlikely candidate. Fine mapping of the
specific amino acids required to cause the cell death phenotype is
required to better determine which viruses might utilize this
mechanism, whether this accounts for the limited ability of the
1918 PB1-F2 to also cause some cell death, and how likely
reversion to this phenotype by mutation to the necessary sequence
might be. However, the current data suggest it is a rare trait in
modern seasonal viruses and in the animal reservoir.
The emergence of the pandemic H1N1 strain in 2009 has
increased the urgency to understand the molecular basis of
virulence of influenza viruses. The currently circulating pandemic
strain does not encode a full-length PB1-F2 protein, so would not
be expected to cause lung inflammation as effectively as previous
pandemic strains. In addition, since the PB1-F2 has been shown to
be a major virulence factor in the genesis and severity of secondary
bacterial infections [10], we and others have predicted that
bacterial pneumonia would be a less frequent complication during
this pandemic than was seen in the 20
th century pandemics [28].
Indeed, although bacterial super-infections complicated more than
95% of all deaths during the 1918 pandemic [29], bacterial
pneumonia has been found on autopsy in only 29% of fatalities
Figure 7. PB1-F2 contributes to influenza virus mediated immunopathology. Groups of mice were infected with a panel of viruses as
indicated (see methods for definitions) and euthanized 72 hours post-infection. Lungs were removed, sufflated, sectioned, and examined for
histopathology following A) staining with hematoxylin and eosin or B) application of an antibody specific for MPO followed by a horse-radish
peroxidase-conjugated secondary antibody, staining with chromagen DAB, and counterstaining with hematoxylin.
doi:10.1371/journal.ppat.1001014.g007
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This could change if the pandemic H1N1 were to acquire a full
length PB1-F2 through reversion of the two stop codons in the
PB1-F2 ORF or by reassortment with a virus encoding a full-
length PB1-F2. Were reversion to occur, the full length PB1-F2 of
the pandemic H1N1 more closely resembles the 1995 H3N2 strain
than the 1968 pandemic precursor, having predicted residues 73R,
75H and 79Q (Figure 1). It also lacks the PR8 specific sequences
seen at amino acids 68–70. Based on this analysis and the data
presented in this study, it is unlikely that reversion of the stop
codons or reassortment of the PB1 gene segment with currently
circulating seasonal influenza strains would provide the pandemic
virus with a functional, pro-inflammatory PB1-F2. Indeed, data
published while this manuscript was in revision indicate that
genetic reversion of the stop codons of the pandemic H1N1 strains
to produce full length PB1-F2 has only minimal effects on
virulence and support for secondary bacterial infections [31].
However, the less likely scenario of reassortment with an avian or
swine virus with a fully functional PB1-F2 remains possible and
could herald enhanced virulence and increased incidence and
severity of secondary bacterial infections.
Materials and Methods
Cell lines and viral infections
Madin-Darby canine kidney (MDCK) cells were grown in
Minimal Essential Medium (MEM) supplemented with 10% heat
inactivated fetal bovine serum (FBS), 2mM glutamine and
antibiotics. A549 cells were grown in F12K medium supplemented
with 10% FBS, 2mM glutamine and antibiotics. Immortalized
MEFS were produced by transfecting primary, unpassaged MEFs
with SV40 genomic DNA using Lipofectamine 2000 (standard
conditions, Invitrogen) and selected by colony formation and
growth. SV40 immortalized wild type and bak
2/2bax
2/2. 293T,
MEF and BAX
2/2BAK
2/2MEF cells were grown in DMEM
medium supplemented with 10% FBS and antibiotics. Cell
cultures were maintained at 37uC in a 5% CO2 incubator. Cells
were washed once with phosphate buffered saline (PBS), infected
with the amount of virus indicated by indicated multiplicity of
infection (MOI) and further incubated as described previously
[10].
Generation of plasmids and viruses
A set of plasmids were generated on the pHW2000 backbone as
described [15,32], encoding for the PB1 gene segment of PR8, A/
Vietnam/1203/04 (H5N1) or A/Wuhan/359/95 (H3N2). In each
of these backgrounds, the open reading frame for PB1-F2 was
disrupted by altering the start codon (T120C mutation by PB1
numbering) so translation will not initiate and inserting a stop
codon after 11 residues (C153G) to insure a complete 1 knock-out
[9,10]. The PR8 PB1-F2 sequence was further altered by
QuikChange site-directed mutagenesis (Stratagene) as described
[10,15] so that the protein expressed was identical to either the A/
Brevig Mission/1/18 (H1N1; 1918 PB1-F2) or A/Beijing/11/56
(H1N1; Beij PB1-F2) virus. In no case did these mutations in the
PB1-F2 reading frame cause non-synonymous mutations in the
PB1 reading frame. The N40 start codon [23] was intact in all
plasmids. These eight PB1 plasmids were then incorporated into a
corresponding set of eight viruses on a 7 gene PR8 backbone (7:1)
by reverse genetics as described [15]. Resulting viruses were
rescued by one passage in MDCK cells then propagated a single
time in eggs for stocks to be used in these studies. All viruses were
fully sequenced to insure no inadvertent mutations occurred
during virus rescue and propagation, then characterized in tissue
culture and eggs as previously described [33]. Expression or lack of
expression of PB1-F2 protein was confirmed for all viruses through
use of confocal microscopy (Figure S2).
Peptide generation
Using the predicted amino acid sequences of the PB1-F2
proteins from PR8, A/Brevig Mission/1/1918, 1/Singapore/1/
1957, A/Hong Kong/1/1968, A/Wuhan/359/1995 and A/
Vietnam/1203/2004, peptides from the C-terminal end were
synthesized as described [10]. The region covered began at amino
acid 61 and extended to the termination of the protein (by PR8
sequence) at amino acid 87 (Figure 1). An additional N-terminal
peptide was synthesized from the PR8 sequence as a positive
control (MGQEQDTPWILSTGHISTQK) as described [10].
Peptides were either synthesized on an Apex 396 multiple organic
synthesizer (Aaaptec, Luisville, KY) or purchased from GenScript
Corporation (Piscataway, NJ). Immediately prior to use in animals
or cell culture, peptides were suspended in PBS at a concentration
of 1mM.
Cell death assays
Peptide exposure assays were conducted in 96 well round
bottom tissue culture dishes, whilst virus infection assays were
conducted in 24 well plates. Cells were seeded at a density of
1610
6 cells/mL for 30min (peptide assays) or overnight (virus
assays) in infection media (cell growth media with BSA substituted
for FCS). Cells were then exposed to 50uM (final concentration) of
peptide for 1h, or infected with virus at the MOI indicated for
periods ranging from 2–12h. Cells from the supernatant and
monolayers were then harvested, washed and stained with APC
labeled Annexin and Propidium Iodide (PI) (Becton Dickinson,
San Jose, CA) for 20min. After a final wash step, cells were
resuspended in 100uL FACs wash buffer (PBS containing 3% BSA
and 0.01% sodium azide) and analysed on the FACs Calibur (BD
Biosciences) and BD CellQuest Pro software (version 5.2.1, BD
Biosciences). Necrotic cellular events were defined as Annexin-V
+
and PI
+, whilst apoptotic events were Annexin-V
+ only. Viable
cells were considered as neither Annexin-V nor PI positive.
Mitochondrial isolation and cytochrome c release
Heavy membrane fractions (referred to as mitochondria) were
purified from 10 grams of fresh liver (duck, ferret and mouse) or 20
chicken embryos day 14, using dounce homogenization and
differential centrifugation in trehalose mitochondrial isolation
buffer (TMIB: 300 mM trehalose, 10 mM HEPES-KOH pH 7.4,
10 mM KCl, 1 mM EDTA, 1 mM EGTA, 0.1% BSA). For
MOMP assays, mitochondria were incubated in TMIB supple-
mented to 110 mM KCl (trehalose mitochondrial assay buffer,
TMAB), 6caspase-8 cleaved mouse BID (R&D Systems) or
peptides (final concentrations are indicated in the text and figure
legends) for 60 minutes at 37uC. Reactions were then fractionated
into supernatant and pellet by centrifugation at 5,5006g for
5 minutes and analyzed by SDS-PAGE and western blot with
anti-cytochrome c. Supernatant and pellet fractions were separated
using the Criterion XT 4–12% gel system (Bio-Rad) with 1X
MOPS buffer at 150 V. Proteins were transferred to nitrocellulose
by standard western conditions, blocked in 5% milk/TBST and
the primary antibody (in blocking buffer: cytochrome c 1:2000,
clone 7H8.2C12 Pharmingen) was incubated overnight at 4uC.
The secondary antibody (1:5000 in blocking buffer) was incubated
at 25uC for 1 hour before standard enhanced chemiluminescence
detection. For MOMP assays, all peptides were resuspended in
anhydrous DMSO (5 mM stock) in a N2 environment, aliquoted,
stored at 280uC and thawed only once. To obtain BAK- and
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isolated from the livers of polydIdC-treated MxCre bak
2/2 bax
f/2
mice. Where indicated, total cytochrome c was determined by a
sample containing mitochondria solubilized in 0.5% CHAPS.
Infectious animal model
Six- to eight week old female Balb/c mice (Jackson Laboratory,
Bar Harbor, ME) were maintained in a Biosafety Level 2 facility in
the Animal Resource Center at SJCRH. All experimental
procedures were done under general anesthesia with inhaled
isoflurane 2.5% (Baxter Healthcare Corporation, Deerfield, IL).
Infectious agents and peptides were diluted in sterile PBS and
administered intranasally in a volume of 100uL (50uL per nare) to
anesthetized mice held in an upright position. Groups of six to ten
mice were weighed and followed at least daily for illness and
mortality. The infectious dose for all experiments was 100 TCID50,
whichwith thesestockscaused10–15%weight lossand no mortality.
Ethics statement
All experimental procedures were approved by the Animal Care
and Use Committee at SJCRH under relevant institutional and
American Veterinary Medical Association guidelines and were
performed in a Biosafety level 2 facility that is accredited by AALAAS.
BAL for cellular cssessment
Following euthanasia by CO2 inhalation, the trachea was
exposed and cannulated with a 21 gauge plastic catheter (BD
Insyte, Becton Dickinson, Sandy, UT). Lungs were lavaged thrice
with 1mL of cold, sterile PBS. Flow cytometry (FACs Calibur,
Becton Dickinson, San Jose, CA) was performed and the number
of white blood cells (WBC) per mL determined (Hemavet 3700,
Drew Scientific, Dallas, TX) on the BALF suspension after red
blood cell depletion using Red Cell Lysis Solution (Sigma). Briefly
cells were stained with 1uL/10
6cells Gr1(FITC)/F480(PER-CP)
for 20 min, washed then resuspended in 100uL FACS wash buffer.
The proportions of Neutrophils (Gr1
+ within the cellular region),
Macrophages (F480
+ within the cellular region) were assessed as a
proportion of cellular events analyzed by flow cytometry as related
to the number of WBC/mL.
Histopathologic examination
Lungs were removed immediately following euthanasia via CO2
inhalation, sufflated and fixed in 10% neutral buffered formalin
overnight. The lungs were processed routinely, embedded in
paraffin and sectioned at 5um. For histopathologic examination,
slides were stained with hematoxylin and eosin and examined
microscopically as previously described [10]. Production of
myeloperoxidase (MPO) by affected tissue was detected via
immunohistochemical staining by the Veterinary Pathology Core
Laboratory at SJCRH. This was done on a LabVision autostainer
at room temperature using tris-buffered saline rinses between
steps. Endogenous peroxidase activity was blocked by incubation
with 3% H2O2 (Humco, Texarkana, TX) for 5 minutes. Slides
were incubated with rabbit anti-human myeloperoxidase (DAKO,
Carpinteria, CA, cat # A0398) at 1:1500 for 30 minutes followed
by incubation with horse-radish peroxidase-conjugated Rabbit-on-
Rodent Polymer (BioCare Medical, Concord, CA, cat #
RMR622) for 30 minutes. Slides were incubated for 5 minutes
with the chromagen DAB (3,39 diaminobenzidine tetrahydrochlor-
ide, cat # K3466, DAKO). Hematoxylin (ThermoShandon, TA-
125-MH) was used as counterstain. Grading and description of
pathology were performed by an experienced veterinary pathol-
ogist (KLB) blinded to the composition of the groups using
methods previously described [33].
Statistical analysis
Comparison of cell death and cellularity of BAL fluid between
groups was done using analysis of variance (ANOVA) for multiple
comparisons and the Student’s t-test for matched, single
comparisons. A p-value of ,0.05 was considered significant for
these comparisons. SigmaStat for Windows (SysStat Software,
Inc., V 3.11) was utilized for all statistical analyses.
Supporting Information
Figure S1 Uptake of PB1-F2 derived peptides into cells. J774
macrophages were incubated with either A) N-terminal PB1-F2
peptide:streptavidin:Cy2, B) streptavidin:Cy2, or C) C-terminal
PB1-F2:streptavidin:Cy2 for 5 hours. Representative sections are
pictured. D) Confocal fluorescent images were taken every
20 minutes from 6 specific locations for 16 hours. Representative
cells showing uptake of PB1-F2 peptide, cytoplasmic distribution,
and degradation are shown at the timepoints pictured. This
compares favorably to distribution and kinetics of the full length
PB1-F2 when expressed from virus [15], although peptide
concentration peaks a few hours earlier since viral replication is
not required. Green staining represents PB1-F2, blue is nuclear
staining, and red is cellular membrane.
Found at: doi:10.1371/journal.ppat.1001014.s001 (3.60 MB TIF)
Figure S2 Expression of PB1-F2 in infected cells. MDCK cells
were infected with a panel of viruses or were mock infected, and
expression and localization of PB1-F2 was examined by confocal
microscopy 12 hours later. No expression of PB1-F2 was detected
in this assay for viruses engineered so that the ORF for the PB1-F2
protein was disrupted.
Found at: doi:10.1371/journal.ppat.1001014.s002 (2.71 MB TIF)
Text S1 Supplementary methods. Confocal laser scanning
microscopy and immunofluorescence.
Found at: doi:10.1371/journal.ppat.1001014.s003 (0.03 MB
DOC)
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